Speaking of results from the BRILACIDIN trial , from what I read and so far understand about BRILACIDIN from the past PR released info, is that it will likely be by each patient very short term. We have read/seen from past released info that BRILACIDIN can , or is believed to reduce the COVID-19 infection by as much as 95% in ONE TREATMENT. Also what I understand is that the drug , BRILACIDIN , only stays in ones system for 14 hours. So if my info and understanding of BRILACIDIN is correct then I have to conclude that the most a patient in the clinical trial would be two treatments as that it seems to me would reduce the infection 100% and therefore render farther BRILICIDIN treatments pointless to administer. Mind you I am NOT a doctor or biomed expert , I am just on my own concluding from what I have read that these COVID infected patient volunteers used in the trial , whether they have moderate or severe case , will be IN and OUT of the trial in a matter of days. NO POINT IN KEEPING CURED PATIENTS AROUND.
So am I missing something ???